Cargando…

Field efficacy of fluralaner (Bravecto(®) chewable tablets) for preventing Babesia canis infection transmitted by Dermacentor reticulatus ticks to dogs

BACKGROUND: The isoxazoline fluralaner is effective for prevention of Babesia canis transmission from infected Dermacentor reticulatus ticks to dogs for 84 days in a controlled environment. This study was designed to evaluate the effectiveness of fluralaner chewable tablets for sustained prevention...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiummo, Rafael, Zschiesche, Eva, Capári, Balázs, Farkas, Róbert, Chiquet, Mathieu, Rapti, Dhimitër, Postoli, Rezart, Audry, Alain, Leschnik, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373369/ https://www.ncbi.nlm.nih.gov/pubmed/37501160 http://dx.doi.org/10.1186/s13071-023-05820-2

Ejemplares similares

Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs treated orally with fluralaner chewable tablets (Bravecto™)
por: Taenzler, Janina, et al.
Publicado: (2015)

A European field assessment of the efficacy of fluralaner (Bravecto(®)) chewable and spot-on formulations for treatment of dogs with generalized demodicosis
por: Petersen, Ivo, et al.
Publicado: (2020)

A randomized, blinded, controlled, multi-centered field study assessing the treatment of gastrointestinal nematode infections in cats with fluralaner plus moxidectin spot-on solution (Bravecto® Plus)
por: Rohdich, Nadja, et al.
Publicado: (2018)

Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs after topical administration of fluralaner spot-on solution
por: Taenzler, Janina, et al.
Publicado: (2016)

Efficacy of fluralaner (Bravecto™ chewable tablets) for the treatment of naturally acquired Linognathus setosus infestations on dogs
por: Kohler-Aanesen, Heike, et al.
Publicado: (2017)

Novel foci of Dermacentor reticulatus ticks infected with Babesia canis and Babesia caballi in the Netherlands and in Belgium
por: Jongejan, Frans, et al.
Publicado: (2015)

The southernmost foci of Dermacentor reticulatus in Italy and associated Babesia canis infection in dogs
por: Olivieri, Emanuela, et al.
Publicado: (2016)

The ability of an oral formulation of afoxolaner to block the transmission of Babesia canis by Dermacentor reticulatus ticks to dogs
por: Beugnet, Frederic, et al.
Publicado: (2014)

Efficacy of orally and topically administered fluralaner (Bravecto(®)) for treatment of client-owned dogs with sarcoptic mange under field conditions
por: Chiummo, Rafael, et al.
Publicado: (2020)

Dermacentor reticulatus and Babesia canis in Bavaria (Germany)—A Georeferenced Field Study with Digital Habitat Characterization
por: Silaghi, Cornelia, et al.
Publicado: (2020)

Efficacy of fluralaner chewable tablets (Bravecto(®)) against Asian longhorned tick (Haemaphysalis longicornis) infestations of dogs
por: Petersen, Melissa, et al.
Publicado: (2023)

Onset of activity of fluralaner (BRAVECTO™) against Ctenocephalides felis on dogs
por: Taenzler, Janina, et al.
Publicado: (2014)

Update on prevalence of Babesia canis and Rickettsia spp. in adult and juvenile Dermacentor reticulatus ticks in the area of Poland (2016–2018)
por: Dwużnik-Szarek, Dorota, et al.
Publicado: (2022)

Comparative speed of kill of sarolaner (Simparica™ Chewables) and fluralaner (Bravecto(®)) against induced infestations of Amblyomma americanum on dogs
por: Six, Robert H., et al.
Publicado: (2016)

The speed of kill of fluralaner (Bravecto™) against Ixodes ricinus ticks on dogs
por: Wengenmayer, Christina, et al.
Publicado: (2014)

Two randomized, controlled studies to assess the efficacy and safety of lotilaner (Credelio™) in preventing Dermacentor reticulatus transmission of Babesia canis to dogs
por: Cavalleri, Daniela, et al.
Publicado: (2017)

Safety of fluralaner chewable tablets (Bravecto(TM)), a novel systemic antiparasitic drug, in dogs after oral administration
por: Walther, Feli M, et al.
Publicado: (2014)

Fluralaner 5.46% (w/w) flavored chewable tablet (Bravecto(®) 1-Month) is effective for treatment of canine generalized demodicosis
por: Rohdich, Nadja, et al.
Publicado: (2022)

Early Babesia canis transmission in dogs within 24 h and 8 h of infestation with infected pre-activated male Dermacentor reticulatus ticks
por: Varloud, Marie, et al.
Publicado: (2018)

Correction to: Fluralaner 5.46% (w/w) favored chewable tablet (Bravecto® 1-Month) is effective for treatment of canine generalized demodicosis
por: Rohdich, Nadja, et al.
Publicado: (2022)

A novel combination of fipronil and permethrin (Frontline Tri-Act®/Frontect®) reduces risk of transmission of Babesia canis by Dermacentor reticulatus and of Ehrlichia canis by Rhipicephalus sanguineus ticks to dogs
por: Jongejan, Frans, et al.
Publicado: (2015)

Dermacentor reticulatus, a putative vector of Babesia cf. microti (syn. Theileria annae) piroplasm
por: Hodžić, Adnan, et al.
Publicado: (2017)

Prevention of Babesia canis in dogs: efficacy of a fixed combination of permethrin and fipronil (Effitix®) using an experimental transmission blocking model with infected Dermacentor reticulatus ticks
por: Navarro, Christelle, et al.
Publicado: (2015)

Rickettsia helvetica in Dermacentor reticulatus Ticks
por: Dobec, Marinko, et al.
Publicado: (2009)

Dermacentor reticulatus: a vector on the rise
por: Földvári, Gábor, et al.
Publicado: (2016)

Update and prognosis of Dermacentor distribution in Germany: Nationwide occurrence of Dermacentor reticulatus
por: Springer, Andrea, et al.
Publicado: (2022)

Treatment of dogs with Bravecto(®) (fluralaner) reduces mosquito survival and fecundity
por: Evans, Christopher Charles, et al.
Publicado: (2023)

Density of Dermacentor reticulatus Ticks in Eastern Poland
por: Zając, Zbigniew, et al.
Publicado: (2020)

A study on the long-term efficacy of Seresto® collars in preventing Babesia canis (Piana & Galli-Valerio, 1895) transmission to dogs by infected Dermacentor reticulatus (Fabricius, 1794) ticks
por: Fourie, Josephus J., et al.
Publicado: (2019)

Efficacy of oral fluralaner (Bravecto) against Tunga penetrans in dogs: A negative control, randomized field study in an endemic community in Brazil
por: dos Santos, Katharine Costa, et al.
Publicado: (2022)

The bacterial microbiome of field-collected Dermacentor marginatus and Dermacentor reticulatus from Slovakia
por: Zhang, Yan-Kai, et al.
Publicado: (2019)

A quantitative evaluation of the extent of fluralaner uptake by ticks (Ixodes ricinus, Ixodes scapularis) in fluralaner (Bravecto(TM)) treated vs. untreated dogs using the parameters tick weight and coxal index
por: Williams, Heike, et al.
Publicado: (2015)

Safety of the concurrent treatment of dogs with Bravecto™ (fluralaner) and Scalibor™ protectorband (deltamethrin)
por: Walther, Feli M, et al.
Publicado: (2014)

Safety of concurrent treatment of dogs with fluralaner (Bravecto™) and milbemycin oxime - praziquantel
por: Walther, Feli M, et al.
Publicado: (2014)

A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto™ (fluralaner) against Frontline™ (fipronil) in flea- and tick-infested dogs
por: Rohdich, Nadja, et al.
Publicado: (2014)

Experimental transmission of Anaplasma marginale by male Dermacentor reticulatus
por: Zivkovic, Zorica, et al.
Publicado: (2007)

Optimization of an artificial tick feeding assay for Dermacentor reticulatus
por: Krull, Christoph, et al.
Publicado: (2017)

Spread of Dermacentor reticulatus is associated with the loss of forest area
por: Mierzejewska, Ewa J., et al.
Publicado: (2017)

Efficacy of In Vitro Lithium Chloride Treatments on Dermacentor reticulatus
por: Kolics, Balázs, et al.
Publicado: (2023)

Efficacy of two topical fluralaner formulations (Bravecto®; Bravecto® Plus) against Asian longhorned tick (Haemaphysalis longicornis) infestations of cats
por: Petersen, Melissa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v1neg7g5intjpvca06202f854l